Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains

Molecular and Cellular Biology

Volumn 22, Issue 24, 2002, Pages 8659-8668

  Ghioni, Pamela ^a   Bolognese, Fabrizio ^a   Duijf, Pascal H G ^c   Van Bokhoven, Hans ^c   Mantovani, Roberto ^b   Guerrini, Luisa ^a  

^a Dipto Genet Biol Microrganismi   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HEAT SHOCK PROTEIN 70; HYBRID PROTEIN; ISOPROTEIN; PROTEIN MDM2; PROTEIN P53; PROTEIN P63;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; COLONY FORMATION; DNA BINDING; ECTODERMAL DYSPLASIA; ECTRODACTYLY; EXON; FRAMESHIFT MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MISSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE; DNA-BINDING PROTEINS; EXONS; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; MUTATION; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0036892018     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.24.8659-8668.2002     Document Type: Article

References (52)

1. Agoff, S. N., J. Hou, D. I. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84-87.
2. Andrew, S. E. 2001. When p63 goes awry: SAM domain mutations. Clin. Genet. 60:11-12.
3. Bamberger, C., and H. Schmale. 2001. Identification and tissue distribution of novel KET/p63 splice variants. FEBS Lett. 501:121-126.
4. Bork, P., and E. V. Koonin. 1998. Predicting functions from protein sequences; where are the bottlenecks? Nat. Genet. 18:313-318.
5. Calabrò, V., G. Mansueto, T. Parisi, M. Vivo, R. Calogero, and G. La Mantia. 2002. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homologue p63. J. Biol. Chem. 277:2674-2681.
6. Calabrò, V., G. Mansueto, T. Parisi, M. Vivo, R. Calogero, and G. La Mantia. 2002. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J. Biol. Chem. 22:196-206.
7. Caspari, T. 2000. Checkpoints: How to activate p53. Curr. Biol. 10:R315-R317.
8. Celli, J., P. Duijf, B. C. J. Hamel, M. Bamshad, B. Kramer, A. P. T. Smits, R. Newbury-Ecob, R. C. M. Hennekam, G. Van Buggenhout, A. van Haeringen, C. G. Woods, A. J. van Essen, R. de Waal, G. Vriend, D. A. Haber, A. Yang, F. McKeon, H. G. Brunner, and H. van Bokhoven. 1999. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99:143-153.
9. Chi, S.-W., A. Ayed, and C. H. Arrowsmith. 1999. Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J. 18:4438-4445.
10. Davison, T. S., C. Vagner, M. Kaghad, A. Ayed, D. Caput, and C. H. Arrow-smith. 1999. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274:18709-18714.
11. De Laurenzi, V., A. Rossi, A. Terrinoni, D. Barcaroli, M. Levrero, A. Costanzo, R. A. Knight, P. Guerrieri, and G. Melino. 2000. p63 and p73 transactivate differentiation gene promoters in human keratinocyte. Biochem. Biophys. Res. Commun. 273:342-346.
12. Dohn, M., S. Zhang, and X. Chen. 2001. p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20:3193-3205.
13. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
14. Gaiddon, C., M. Lokshin, J. Ahn, T. Zhang, and C. Prives. 2001. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol. Cell. Biol. 21:1874-1887.
15. Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren. 1991. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979-9983.
16. Hansen, S. K., L. Guerrini, and F. Blasi. 1994. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor. J. Biol. Chem. 269:22230-22237.
17. Ianakiev, P., M. W. Kilpatrick, I. Toudjarska, D. Basel, P. Beighton, and P. Tsipouras. 2000. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am. J. Hum. Genet. 67:59-66.
18. Irwin, M. S., and W. G. Kaelin. 2001. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ. 12:337-349.
19. Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J. C. Biscan, A. Valent, A. Minty, P. Chalon, J. M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
20. Katoh, I., K. Aisaki, S. Kurata, S. Ikawa, and Y. Ikawa. 2000. p51A (TAp63γ), a p53 homolog, accumulates in response to DNA damage for cell regulation. Oncogene 19:3126-3130.
21. Kong, X. T., V. A. Valentine, S. T. Rowe, M. B. Valentine, S. T. Ragsdale, B. G. Jones, D. A. Wilkinson, G. M. Brodeur, S. L. Cohn, and A. T. Look. 1999. Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines. Neoplasia 1:80-89.
22. Krause, K., M. Wasner, W. Reinhard, U. Haugwitz, C. L. Dohna, J. Mossner, and K. Engeland. 2000. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res. 28:4410-4418.
23. Landsberger, N., and A. P. Wolffe. 1995. Role of chromatin and Xenopus laevis heat shock transcription factor in regulation of transcription from X. laevis hsp70 promoter in vivo. Mol. Cell. Biol. 15:6013-6024.
24. Lee, C. W., and N. B. La Thangue. 1999. Promoter specificity and stability control of the p53-related protein p73. Oncogene 18:4171-4181.
25. Lemon, B., and R. Tjian. 2000. Orchestrated response: A symphony of transcription factors for gene control. Genes Dev. 14:2551-2569.
26. Levrero, M., V. De Laurenzi, A. Costanzo, S. Sabatini, J. Gong, J. Y. J. Wang, and G. Melino. 2000. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J. Cell Sci. 113:1661-1670.
27. Liberati, C., A. di Silvio, S. Ottolenghi, and R. Mantovani. 1999. NF-Y binding to twin CCAAT boxes: Role of Q-rich domains and histone fold helices. J. Mol. Biol. 285:1441-1455.
28. Lohrum, M. A. E., and K. H. Vousden. 2000. Regulation and function of the p53-related proteins: Same family, different rules. Trends Cell Biol. 10:197-202.
29. Majello, B., P. De Luca, G. Hagen, G. Suske, and L. Lania. 1994. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914-4921.
30. Majello, B., P. De Luca, and L. Lania. 1997. Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J. Biol. Chem. 272:4021-4026.
31. Marin, M. C., and W. G. Kaelin, Jr. 2000. p63 and p73: Old members of a new family. Biochim. Biophys. Acta 1470:M93-M100.
32. May, P., and E. May. 1999. Twenty years of p53 research: Structural and functional aspects of the p53 protein. Oncogene 18:7621-7636.
33. McGrath, J. A., P. H. G. Duijf, V. Doetsch, A. D. Irvine, R. de Waal, K. R. J. Vanmolkot, V. Wessagowit, A. Kelly, D. J. Atherton, W. A. D. Griffiths, S. J. Orlow, A. van Haeringen, M. G. E. M. Ausems, A. Yang, F. McKeon, M. A. Bamshad, H. G. Brunner, B. C. J. Hamel, and H. van Bokhoven. 2001. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum. Mol. Genet. 10:1-9.
34. Michael, D., and M. Oren. 2002. The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 12:53-59.
35. Mills, A. A., B. Zheng, X.-J. Wang, H. Vogel, D. R. Roop, and A. Bradley. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.
36. Nishi, H., M. Senoo, K. H. Nishi, B. Murphy, T. Rikiyama, Y. Matsumura, S. Habu, and A. C. Johnson. 2001. p53 homologue p63 represses epidermal growth factor receptor expression. J. Biol. Chem. 276:41717-41724.
37. Osada, M., M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa. 1998. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4:839-843.
38. Ozaki, T., M. Naka, N. Takada, M. Tada, S. Sakiyama, and A. Nakagawara. 1999. Deletion of the COOH-terminal region of p73a enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells. Cancer Res. 59:5902-5907.
39. Pellegrini, G., E. Dellambra, O. Golisano, E. Martinelli, I. Fantozzi, S. Bondanza, D. Ponzin, F. McKeon, and M. De Luca. 2001. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 98:3156-3161.
40. Piechaczyk, M., J. M. Blanchard, L. Marty, C. Dani, F. Panabieres, S. El Sabouty, P. Fort, and P. Jeanteur. 1984. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res. 25:6951-6963.
41. Raycroft, L., J. R. Schmidt, K. Yoas, M. Hao, and G. Lozano. 1991. Analysis of p53 mutants for transcriptional activity. Mol. Cell. Biol. 11:6067-6074.
42. Strano, S., E. Munarriz, M. Rossi, L. Castagnoli, Y. Shaul, A. Sacchi, M. Oren, M. Sudol, G. Cesareni, and G. Blandino. 2001. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 276:15164-15173.
43. Takada, N., T. Ozaki, S. Ichimiya, S. Todo, and A. Nakagawara. 1999. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res. 59:2810-2814.
44. Thanos, C. D., and J. U. Bowie. 1999. p53 family members p63 and p73 are SAM domain-containing proteins. Protein Sci. 8:1708-1710.
45. Ueda, Y., M. Hijikata, S. Takagi, T. Chiba, and K. Shimotohno. 1999. New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene 18:4993-4998.
46. van Bokhoven, H., B. C. J. Hamel, M. Bamshad, E. Sangiorgi, F. Gurrieri, P. H. G. Duijf, K. R. J. Vanmolkot, E. van Beusekom, S. E. C. van Beersum, J. Celli, G. F. M. Merkx, R. Tenconi, J. P. Fryns, A. Verloes, R. A. Newbury-Ecob, A. Raas-Rotschild, F. Majewski, F. A. Beemer, A. Janecke, D. Chitayat, G. Crisponi, H. Kayserili, J. R. W. Yates, G. Neri, and H. G. Brunner. 2001. p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am. J. Hum. Gen. 69:481-492.
47. Wang, X. W., and C. C. Harris. 1997. p53 tumor-suppressor gene: Clues to molecular carcinogenesis. J. Cell. Physiol. 173:247-255.
48. Yang, A., and F. McKeon. 2000. p63 and p73: p53 mimics, menaces and more. Mol. Cell. Biol. 1:199-207.
49. Yang, A., M. Kaghad, Y. Wang, E. Gillett, M. D. Fleming, V. Dotsch, N. C. Andrews, D. Caput, and F. McKeon. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2:305-316.
50. Yang, A., N. Walker, R. Bronson, M. Kaghad, M. Oosterwegel, J. Bonnin, C. Vagner, H. Bonnet, P. Dikkes, A. Sharpe, F. McKeon, and D. Caput. 2000. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103.
51. Yang, A., R. Schweitzer, D. Sun, M. Kaghad, N. Walker, R. T. Bronson, C. Tabin, A. Sharpe, D. Caput, C. Crum, and F. McKeon. 1999. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718.
52. Zauberman, A., D. Flusberg, Y. Haupt, Y. Barak, and M. Oren. 1995. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res. 23:2584-2592.